- Home
- HCI vs NXPLW Comparison
HCI vs NXPLW Comparison
Compare HCI & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- NXPLW
- Stock Information
- Founded
- HCI 2006
- NXPLW N/A
- Country
- HCI United States
- NXPLW United States
- Employees
- HCI N/A
- NXPLW N/A
- Industry
- HCI Property-Casualty Insurers
- NXPLW Telecommunications Equipment
- Sector
- HCI Finance
- NXPLW Telecommunications
- Exchange
- HCI Nasdaq
- NXPLW Nasdaq
- Market Cap
- HCI N/A
- NXPLW N/A
- IPO Year
- HCI N/A
- NXPLW N/A
- Fundamental
- Price
- HCI $117.49
- NXPLW $0.21
- Analyst Decision
- HCI Buy
- NXPLW
- Analyst Count
- HCI 5
- NXPLW 0
- Target Price
- HCI $140.00
- NXPLW N/A
- AVG Volume (30 Days)
- HCI 69.2K
- NXPLW 6.4K
- Earning Date
- HCI 02-27-2025
- NXPLW 03-31-2025
- Dividend Yield
- HCI 1.36%
- NXPLW N/A
- EPS Growth
- HCI 163.93
- NXPLW N/A
- EPS
- HCI 11.94
- NXPLW N/A
- Revenue
- HCI $750,846,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- HCI N/A
- NXPLW N/A
- Revenue Next Year
- HCI $20.16
- NXPLW N/A
- P/E Ratio
- HCI $9.84
- NXPLW N/A
- Revenue Growth
- HCI 48.73
- NXPLW 179.89
- 52 Week Low
- HCI $83.65
- NXPLW $0.25
- 52 Week High
- HCI $126.50
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- HCI 42.65
- NXPLW N/A
- Support Level
- HCI $115.65
- NXPLW N/A
- Resistance Level
- HCI $121.42
- NXPLW N/A
- Average True Range (ATR)
- HCI 2.57
- NXPLW 0.00
- MACD
- HCI -0.70
- NXPLW 0.00
- Stochastic Oscillator
- HCI 19.68
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.